Larvol Delta - Mayo-Clinic-preparing-to-Commence-Phase-II-FDA-clinical-trial-for-the-treatment-of-COVID19-with-Vicromax

Vicromax (merimepodib) - BioSig Tech

http://www.globenewswire.com/news-release/2020/04/16/2017414/0/en/Mayo-Clinic-preparing-to-Commence-Phase-II-FDA-clinical-trial-for-the-treatment-of-COVID-19-with-Vicromax.html

Apr 16, 2020

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next